Wall Street is positive on Avid Bioservices Inc (CDMO). On average, analysts give CDMO a Buy rating. The average price target is $28.333, which means analysts expect the stock to climb by 78.19% over the next twelve months.
That average ranking earns CDMO an Analyst Rating of 33, which is better than 33% of stocks based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What’s Happening With Avid Bioservices Inc Stock Today?
Avid Bioservices Inc (CDMO) stock is trading at $15.90 as of 12:51 PM on Tuesday, Nov 1, a drop of -$1.04, or -6.14% from the previous closing price of $16.94. The stock has traded between $15.44 and $16.87 so far today. Volume today is light. So far 456,486 shares have traded compared to average volume of 716,081 shares.
Click Here to get the full Stock Report for Avid Bioservices Inc stock.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Read More: Where Does Wall Street Think Avid Bioservices Inc (CDMO) Stock Will Go?